These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38985193)

  • 1. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study.
    Lo Re M; Polverino P; Rivetti A; Pecoraro A; Saladino M; Pezzoli M; Siena G; De Nunzio C; Li Marzi V; Gacci M; Serni S; Campi R; Sessa F
    World J Urol; 2024 Jul; 42(1):402. PubMed ID: 38985193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
    de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
    Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial.
    Bertolo R; Iacovelli V; Cipriani C; Carilli M; Vittori M; Antonucci M; Maiorino F; Signoretti M; Petta F; Travaglia S; Panei M; Bove P
    BJU Int; 2023 Jul; 132(1):100-108. PubMed ID: 36917033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three years outcomes of transperineal laser ablation of the prostate.
    Minafra P; DE Rienzo G; Gerbasi S; Cindolo L; Battaglia M; Ditonno P
    Minerva Urol Nephrol; 2023 Aug; 75(4):471-478. PubMed ID: 37314812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.
    van Kollenburg R; van Riel L; Bloemen P; de Reijke T; Beerlage H; de Bruin D; Oddens J
    BJUI Compass; 2024 Jan; 5(1):52-59. PubMed ID: 38179027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
    Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
    World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transperineal Laser Ablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Long-Term Follow-Up in 40 Patients.
    Patelli G; Altieri VM; Ierardi AM; Carnevale A; Chizzoli E; Baronchelli F; Trimarchi R; Carrafiello G
    J Vasc Interv Radiol; 2024 Aug; 35(8):1187-1193. PubMed ID: 38705571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience.
    Frego N; Saita A; Casale P; Diana P; Contieri R; Avolio PP; Lazzeri M; Hurle R; Buffi NM; Guazzoni GF; Lughezzani G
    World J Urol; 2021 Oct; 39(10):3867-3873. PubMed ID: 33811512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study.
    Canat HL; Gurbuz C; Bozkurt M
    Int Urol Nephrol; 2023 Nov; 55(11):2747-2752. PubMed ID: 37498422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
    Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.
    Pacella CM; Patelli G; Iapicca G; Manenti G; Perretta T; Ryan CP; Esposito R; Mauri G
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):356-363. PubMed ID: 31827239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal Laser Ablation for Focal Therapy of Localized Prostate Cancer: 12-Month Follow-up Outcomes from a Single Prospective Cohort Study.
    Iacovelli V; Carilli M; Bertolo R; Forte V; Vittori M; Filippi B; Di Giovanni G; Cipriani C; Petta F; Maiorino F; Signoretti M; Antonucci M; Guidotti A; Travaglia S; Caputo F; Manenti G; Bove P
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy.
    Cai HJ; Fang JH; Kong FL; Xu CK; Chen CH; Wang W; Huang B
    Acta Radiol; 2022 Apr; 63(4):553-558. PubMed ID: 33779301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes.
    Polverino P; Lo Re M; Saladino M; Pecoraro A; Moscardi L; Rivetti A; Resta GR; Pezzoli M; Romano A; Somani BK; Siena G; Cocci A; Gacci M; Minervini A; Serni S; Campi R; Sessa F
    Minerva Urol Nephrol; 2024 Oct; 76(5):646-649. PubMed ID: 38093618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
    van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
    JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
    Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
    Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor for the article "Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study".
    Zhao Y; Yang J
    World J Urol; 2024 Sep; 42(1):502. PubMed ID: 39225861
    [No Abstract]   [Full Text] [Related]  

  • 19. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
    Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
    World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified holmium laser enucleation for benign prostatic obstruction to preserve sexual and ejaculatory function.
    Long Depaquit T; Baboudjian M; Chiron P; Corral R; Anastay V; Bastide C; Toledano H
    Fr J Urol; 2024 Mar; 34(2):102581. PubMed ID: 38717462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.